نتائج البحث

Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel

• Source: A Phase 3 Open-Label Extension Study to Evaluate the Long-Term Safety of Omiganan Topical Gel in Subjects With Rosacea

تفاصيل العنوان

Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis

• Source: A Phase 2, Randomized, Vehicle and Ketoconazole-Controlled, Evaluator-Blinded, Study to Explore the Efficacy, Pharmacodynamics and Safety of Omiganan 1.75% Topical Gel

تفاصيل العنوان

Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers

• Source: A Randomized, Evaluator-blinded, Vehicle-controlled Study to Explore the Pharmacodynamic Effects of Omiganan and Omiganan in Combination

تفاصيل العنوان

Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis

• Source: A Randomized, Double-blind, Placebo-controlled Study to Assess the Pharmacodynamics, Safety, Tolerability and Efficacy of Omiganan BID in Patients With Mild to Moderate

تفاصيل العنوان

Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN

• Source: A Phase 2, Randomized, Double-Blind, Parallel-Group Study to Assess the Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With Usual

تفاصيل العنوان

Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts

• Authors : Leiden University Medical Center

• Source: A Phase 2, Randomized, Vehicle-Controlled, Double-Blind, Parallel-Group Study to Explore the Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With

تفاصيل العنوان

A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris

• Source: A Phase 2, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Multicenter Study to Evaluate the Safety and Efficacy of CLS001 Topical Gel Versus Vehicle Applied Once Daily for 12 Weeks to

تفاصيل العنوان

Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis

• Source: A Randomized, Double-blind, Placebo Controlled Study to Assess the Pharmacodynamics, Safety/Tolerability and Efficacy of Omiganan in Patients With Mild to Moderate

تفاصيل العنوان

Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects

• Authors : Catherine Hardalo, MD. Vice President, Anti Infectives Clinical Development

• Source: A Single- Center, Open-Label, Study of the Persistence of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult

تفاصيل العنوان

Study of Omiganan 1% Gel in Preventing Catheter Infections/Colonization in Patients With Central Venous Catheters

• Authors : Catherine Hardalo, MD. Vice President, Anti Infectives Clinical Development

• Source: A Phase 3, Multicenter, Randomized, Evaluation Committee-Blinded Study to Assess the Efficacy of Topical Omiganan 1% Gel in Preventing Local Catheter Site

تفاصيل العنوان